Feb 14, 2023 / 09:20PM GMT
Marc Goodman - SVB Securities - Analyst
Okay. Good afternoon, everybody. Welcome back to the next session of the SVB Securities Healthcare Conference. I'm Marc Goodman, one of the biopharma analysts. And we're lucky enough to have Outlook Therapeutics joining us right now.
We have Russ Trenary, who's going to give a presentation. He's the CEO. And he's been CEO of the company probably for about 1.5 years now, but I've known Russ a very long time. We've done ophthalmology work together for years upon years. And so very exciting time for the company.
Obviously, a product is hopefully going to get approved and launched. And Russ is going to take us through the story. So please, Russ, I'll turn it over to you.
Russ Trenary - Outlook Therapeutics, Inc. - President & CEO
Appreciate it so much, Marc. Thanks again for the invite. It's great to be here. So this first slide is not just a throwaway slide when we say that we're here to enhance the standard of care for retinal disorders. If you can understand by the end of this presentation how we're
Outlook Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers